Skip to main content
. 2023 Mar 9;18(3):e0282587. doi: 10.1371/journal.pone.0282587

Table 2. Patients’ characteristics.

Characteristics n = 145,769
Gender (%)
    Female 71,891 (49.3)
    Male 73,855 (50.7)
    Other/ Unknown <25 (0.0)
Age (mean (SD)) 59.2 y (19.5)
Race (%)
    Asian 5,305 (3.6)
    Black 32,467 (22.3)
    Native Haw./Pac. Islander 318 (0.2)
    White 75,658 (51.9)
    Other/ Unknown 30,883 (21.2)
Ethnicity (%)
    Hispanic/Latino 29,419 (20.2)
    Not Hispanic/Latino 104,200 (71.5)
    Other/ Unknown 12,068 (8.3)
OS at day 1 (%)
    OS 1—outpatient 35,328 (24.2)
    OS 3—hospitalized 94,601 (64.9)
    OS 5—hospitalized on Oxygen 9,326 (6.4)
    OS 7—hospitalized on Mechanical Ventilator 6,252 (4.3)
    OS 9—hospitalized on ECMO 262 (0.2)
    OS 11—death 0 (0)
BMI (mean (SD)) 31.0 (7.1)
Comorbidities (%)
Hypertension 92,767 (63.6)
Diabetes Mellitus 33,808 (23.2)
Myocardial Infarction 19,197 (13.2)
Congestive Heart Failure 31,629 (21.7)
Peripheral Vascular Disease 24,011 (16.5)
Stroke 24,168 (16.6)
Dementia 13,037 (8.9)
Chronic Pulmonary Disease 40,545 (27.8)
Rheumatologic Disease 8,998 (6.2)
Mild Liver Disease 15,014 (10.3)
Severe Liver Disease 4,972 (3.4)
Upper GI bleed 4,791 (3.3)
Renal Disease 33,848 (23.2)
Peptic Ulcer Disease 4,496 (3.1)
Paralysis 5,116 (3.5)
Cancer 14,397 (9.9)
Diabetes with chronic complications
27,186 (18.7)
Metastatic solid tumor 5,376 (3.7)
HIV/AIDS 1,527 (1.0)
Quarter of Diagnosis (%)
Jan-Mar 2020 6,956 (4.8)
Apr-Jun 2020 28,837 (19.8)
Jul-Sep 2020 17,111 (11.7)
Oct-Dec 2020 44,210 (30.3)
Jan-Mar 2021 33,468 (23.0)
Apr-Jun 2021 15,173 (10.4)
Outcomes (%, IQR)
Discharged 128,063 (87.9, 8)
Death 17,706 (12.1, 13)